rs1553544158
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001172509.2(SATB2):c.1592dupA(p.Asn531LysfsTer21) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001172509.2 frameshift
Scores
Clinical Significance
Conservation
Publications
- chromosome 2q32-q33 deletion syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- SATB2 associated disorderInheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SATB2 | NM_001172509.2 | c.1592dupA | p.Asn531LysfsTer21 | frameshift_variant | Exon 10 of 11 | ENST00000417098.6 | NP_001165980.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Chromosome 2q32-q33 deletion syndrome Pathogenic:1
While this particular variant has not been reported in the literature, loss-of-function variants in SATB2 are known to be pathogenic (PMID: 25885067, 17377962, 26596517). For these reasons, this variant has been classified as Pathogenic. This sequence change inserts 1 nucleotide in exon 11 of the SATB2 mRNA (c.1592dupA), causing a frameshift at codon 531. This creates a premature translational stop signal (p.Asn531Lysfs*21) and is expected to result in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at